Phase I trial of AB 224050
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2014
At a glance
- Drugs AB 224050 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Active Biotech
- 24 Mar 2014 Status changed from planning to discontinued.
- 15 Mar 2007 New trial record.